SEARCH

SEARCH BY CITATION

References

  • 1
    Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, Stern JB, Travis WD. Cutaneous pathology in Wegener’s granulomatosis: a clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol 1995; 19: 161.
  • 2
    Daoud MS, Gibson LE, DeRemee RA, Specks U, El-Azhary RA, Su WP. Cutaneous Wegener’s granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol 1994; 31: 605.
  • 3
    Frances C, Du LT, Piette JC, et al. Wegener’s granulomatosis: dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994; 130: 861.
  • 4
    Gibson LE, Su WP. Cutaneous vasculitis. Rheum Dis Clin North Am 1995; 21: 1097.
  • 5
    Hu CH, O’Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener granulomatosis. Arch Dermatol 1977; 113: 175.
  • 6
    Norris MJ, Tomecki KJ, Bergfeld WF, Wilke WS. Cutaneous Wegener’s granulomatosis: report of a case and review of the literature. Cleve Clin J Med 1988; 55: 181.
  • 7
    Hall JB, Wadham BM, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N Z J Med 1984; 14: 277.
  • 8
    Van Der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1985; 1: 425.
  • 9
    Tervaert JW, Van Der Woude FJ, Fauci AS, et al. Association between active Wegener’s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461.
  • 10
    Geffriaud-Ricouard C, Noel LH, Chauveau D, Houhou S, Grunfeld JP, Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993; 39: 125.
  • 11
    Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421.
  • 12
    Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488.
  • 13
    Nolle B, Specks U, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 1989; 111: 28.
  • 14
    Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000; 57: 846.
  • 15
    Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, DeRemee RA. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener’s granulomatosis. Mayo Clin Proc 1989; 64: 28.
  • 16
    Stone JH, Talor M, Stebbing J, et al. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 2000; 13: 424.
  • 17
    Jenne DE, Tschopp J, Lüdemann J, Utecht B, Gross WL. Wegener’s autoantigen decoded [Letter]. Nature 1990; 346: 520.
  • 18
    Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener’s granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989; 74: 1888.
  • 19
    Ludemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener’s granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990; 171: 357.
  • 20
    Tervaert JW, Goldschmeding R, Elema JD, et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990; 33: 1264.
  • 21
    Schönermarck U, Lamprecht P, Csernok E, Gross WL. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 2001; 40: 178.
  • 22
    Gibson LE, Specks U, Homburger H. Clinical utility of ANCA tests for the dermatologist. Int J Dermatol 2003; 42: 859.
  • 23
    Gibson LE, Daoud MS, Muller SA, Perry HO. Malignant pyodermas revisited. Mayo Clin Proc 1997; 72: 734.
  • 24
    Perry HO, Winkelmann RK, Muller SA, Kierland RR. Malignant pyodermas. Arch Dermatol 1968; 98: 561.
  • 25
    Magro CM, Crowson AN. Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction pattern reflecting systemic disease. J Cutan Pathol 1998; 25: 215.
  • 26
    Daoud MS, Gibson LE, Dahl PR, Muller SA. Cutaneous Wegener’s granulomatosis presenting as pyoderma gangrenosum-like ulceration. Eur J Dermatol 1995; 5: 23.
  • 27
    Lerner EA, Dover JS. Malignant pyoderma: a manifestation of Wegener’s granulomatosis? J Am Acad Dermatol 1986; 15: 1051.
  • 28
    Thomas RH, Payne CM, Black MM. Wegener’s granulomatosis presenting as pyoderma gangrenosum. Clin Exp Dermatol 1982; 7: 523.
  • 29
    Wernikoff S, Merritt C, Briggaman RA, Woodley DT. Malignant pyoderma or pyoderma gangrenosum of the head and neck? Arch Dermatol 1987; 123: 371.
  • 30
    Finan MC, Winkelmann RK. Cutaneous extravascular necrotizing granuloma and lymphocytic lymphoma. Arch Dermatol 1983; 119: 419.
  • 31
    Hamacher KL, Gibson LE. Cutaneous palisaded allergic granuloma associated with rheumatic disease. Int J Dermatol 2002; 41: 230.
  • 32
    Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol 1996; 27: 50.
  • 33
    Burrows NP, Lockwood CM. Antineutrophil cytoplasmic antibodies and their relevance to the dermatologist. Br J Dermatol 1995; 132: 173.
  • 34
    Boomsma MM, Stegeman CA, Van Der Leij MJ, et al. Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000; 43: 2025.
  • 35
    Russell KA, Wiegert E, Schroeder DR, Homburger HA, Specks U. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. Clin Immunol 2002; 103: 196.